Skip to main content

Table 1 Patients’ socio-demographic and clinical characteristics at baseline

From: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

Characteristicsa PAS (N = 70) Interviewed patients (N = 19)
Sex, n (%)   
 Male 52 (74.3%) 15 (78.9%)
 Female 18 (25.7%) 4 (21.1%)
Age, years
 Mean (SD) 70.2 (11.2) 72.2 (8.2)
 Median 73.0 72.0
 95% CI 67.5–72.9 68.3–76.2
Region, n (%)
 North America 40 (57.1%) 17 (89.5%)
 Europe 22 (31.4%) 2 (10.5%)
 Rest of the world 8 (11.4%) 0 (0.0%)
ECOG PS at baseline (n, %)
 0 38 (54.3%) 10 (52.6%)
 1 32 (45.7%) 9 (47.4%)
Site of primary tumor (n, %)
 Non-skin 9 (12.9%) 4 (21.1%)
 Skin 55 (78.6%) 14 (73.7%)
 Missing 6 (8.6%) 1 (5.3%)
Tumor size at baseline (mm)
 n (missing) 61 (9) 16 (3)
 Mean (SD) 103.7 (79.7) 83.3 (49.9)
 Median 83.0 78.5
 95% CI 83.3–124.1 56.7–109.8
Time since initial diagnosis (years)
 Mean (SD) 2.2 (0.8) 2.3 (0.8)
 Median 2.0 2.0
 95% CI 2.0–2.4 2.0–2.7
Time since first metastatic disease (months)
 Mean (SD) 16.9 (23.4) 16.3 (10.4)
 Median 9.5 14.0
 95% CI 11.4–22.5 11.3–21.2
Number of previous therapy lines (n, %)
 Mean (SD) 1.5 (0.7) 1.3 (0.5)
 Median 1.0 1.0
 95% CI 1.3–1.6 1.1–1.6
  1. CI confidence interval, ECOG PS Eastern Cooperative Oncology Group performance status, PAS PRO analysis set, SD standard deviation
  2. ECOG PS: 0 = fully active; 1 = restricted in physically strenuous activity
  3. aMissing data included in calculation of percentages